Xequel Bio, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
Evaluation of the Safety, Tolerability and Efficacy of iNexin™ for the Treatment of the Signs and Symptoms Associated With Dry Eye Disease
- Conditions
- Dry Eye Disease
- Interventions
- Drug: iNexin™ (2.0% aCT1)Drug: Vehicle (eye drop formulation without aCT1)Drug: iNexin™ (0.4% aCT1)Drug: iNexin™ (0.08% aCT1)
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Xequel Bio, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05031806
- Locations
- 🇺🇸
Andover Eye Associates, Andover, Massachusetts, United States
Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing
- Conditions
- Second Degree BurnThermal Burn
- Interventions
- Drug: Vehicle gel
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Xequel Bio, Inc.
- Registration Number
- NCT04684121
Study to Evaluate the Safety of FSR Peptide Versus Placebo Following Punch Biopsy
- Conditions
- Wound Heal
- Interventions
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2020-07-20
- Lead Sponsor
- Xequel Bio, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT04473859
- Locations
- 🇨🇭
Swiss Pharma Contract Ltd, Allschwil, Switzerland
A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery
- Conditions
- ScarringMammoplastyScarBreast Reconstruction
- Interventions
- First Posted Date
- 2020-04-02
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Xequel Bio, Inc.
- Target Recruit Count
- 184
- Registration Number
- NCT04331080
- Locations
- 🇺🇸
Private Clinic- David Kulber, Los Angeles, California, United States
🇺🇸Miami Plastic Surgery, Miami, Florida, United States
🇺🇸Integrated Aesthetics, Spring, Texas, United States
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2020-05-29
- Lead Sponsor
- Xequel Bio, Inc.
- Target Recruit Count
- 124
- Registration Number
- NCT02667327
- Locations
- 🇭🇺
Strazsahegy Medicina Bt., Zrinyi utca 226, Budapest, Hungary
🇮🇳Anand Multispecialty Hospital, Vadodara, Gujarat, India
🇮🇳Marwari Hospital and Research Centre, Guwahati, India
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
- First Posted Date
- 2016-01-12
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Xequel Bio, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02652572
- Locations
- 🇺🇸
Aiyan Diabetes Center, Augusta, Georgia, United States
🇺🇸Spartanburg Regional Healthcare System, Spartanburg, South Carolina, United States
🇺🇸Salem VA Medical Center, Salem, Virginia, United States
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
- First Posted Date
- 2016-01-12
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Xequel Bio, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT02652754
- Locations
- 🇺🇸
Spartanburg Regional Healthcare System, Spartanburg, South Carolina, United States
🇺🇸Aiyan Diabetes Center, Augusta, Georgia, United States
🇺🇸Salem VA Medical Center, Salem, Virginia, United States